Advertisement
Advertisement
U.S. Markets open in 2 hrs 53 mins
Advertisement
Advertisement
Advertisement
Advertisement

Aclaris Therapeutics, Inc. (ACRS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
12.69+0.18 (+1.44%)
At close: 04:00PM EST
12.69 0.00 (0.00%)
After hours: 04:01PM EST
Advertisement
Full screen
Loading interactive chart...
  • Simply Wall St.

    Here's Why We're Not Too Worried About Aclaris Therapeutics' (NASDAQ:ACRS) Cash Burn Situation

    We can readily understand why investors are attracted to unprofitable companies. By way of example, Aclaris...

  • GlobeNewswire

    Aclaris Therapeutics to Host Virtual R&D Day on December 7, 2021

    Investigational New Drug Application for ATI-2138 Allowed WAYNE, Pa., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that it will host a virtual R&D Day on Tuesday, December 7, 2021 from 10:00 a.m. to 12:00 p.m. ET. “We are pleased to announce that the IND application for ATI-2138, an investigational oral small molecule ITK/TXK/JAK

  • GlobeNewswire

    Aclaris Therapeutics to Participate in Upcoming Investor Conferences

    WAYNE, Pa., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that management will participate in the following upcoming investor conferences: Jefferies London Healthcare Conference. Dr. Neal Walker, the President and CEO of Aclaris, will participate in a virtual fireside chat which will be available beginning on Thursday, November 18

Advertisement
Advertisement